Dear Professor Levy
We like your effort and waiting for IMPRESS DAY .
Reza
Iran
From: Mitchell Levy <[email protected]>
To: Mary Daly <[email protected]>; Lori Harmon <[email protected]>; "[email protected]" <[email protected]>
Sent: Wednesday, September 4, 2013 9:21 AM
Subject: Re: [Sepsis Groups] Important Announcement - IMPRESS study to be conducted
To: Mary Daly <[email protected]>; Lori Harmon <[email protected]>; "[email protected]" <[email protected]>
Sent: Wednesday, September 4, 2013 9:21 AM
Subject: Re: [Sepsis Groups] Important Announcement - IMPRESS study to be conducted
Thanks, Mary Ann.
All the best,
Mitchell
On 9/3/13 5:53 PM, "Mary Daly" <[email protected]> wrote:
All the best,
Mitchell
On 9/3/13 5:53 PM, "Mary Daly" <[email protected]> wrote:
Congratulations Drs. Rhodes and Levy; this is indeed an IMPRESSive undertaking
Thanks,
Mary Ann Daly, RN BSN CCRN DC
Regional Clinical Initiative Lead-Sepsis and ICU Liberation (ABCDE)
Gordon and Betty Moore Foundation Grant
Sutter Health Sacramento Sierra Region
E-mail: dalym1@SutterHealth.org <mailto:[email protected]>
Blackberry: 916.200.5604 Office: 916.614.6370
?
You never change things by fighting the existing reality. To change something, build a new model that makes the existing model obsolete. R. Buckminster Fuller
From: [email protected] [mailto:[email protected]] On Behalf Of Lori Harmon
Sent: Friday, August 30, 2013 1:10 PM
To: [email protected]
Subject: [Sepsis Groups] Important Announcement - IMPRESS study to be conducted
Colleagues,
The Surviving Sepsis Campaign will conduct a point prevalence study, the International Multicentre PREvalence Study on Sepsis <http://impress-ssc.com/> (IMPRESS), on November 7, 2013, to better understand the global burden of severe sepsis and septic shock in adult patients. Conducted by the Society of Critical Care Medicine and the European Society of Intensive Care Medicine, under the framework of the Surviving Sepsis Campaign, IMPRESS aims to help clinicians and researchers better understand the global burden of sepsis. De-identified patient-level data will be collected on patients presenting to a participating intensive care unit (ICU) or emergency department with severe sepsis or septic shock within a 24-hour period, midnight to midnight on November 7, 2013. Data collected as part of routine clinical care, including hospital and ICU characteristics, patient characteristics, severity of illness, adherence to Surviving Sepsis Campaign bundle elements, and mortality, will be used for this study.
Led by investigators Andrew Rhodes, FRCP, FRCA, FFICM, and Mitchell M. Levy, MD, FCCM, the study will reveal important information that is currently lacking on the incidence of severe sepsis and septic shock throughout the world. These data will help inform the next steps toward improvement, as well as provide insights into the number of people who lose their lives to this illness.
Interested hospitals from all countries are encouraged to visit www.impress-ssc.com/ <http://www.impress-ssc.com/> for further details or to register for the study. Instructions and information on institutional review board approvals will be forthcoming. On behalf of the Surviving Sepsis Campaign, I extend an encouraging word to your team to mark this date and plan to participate in this very important groundbreaking event.
Best,
Lori A. Harmon, RRT, MBA
Director, Program Development
Society of Critical Care Medicine
500 Midway Drive
Mount Prospect, IL 60056
O +1-847-493-6403
F +1-847-493-6428
[email protected]
http://www.sccm.org/ <http://www.sccm.org/>
_______________________________________________
Sepsisgroups mailing list
[email protected]
http://lists.sepsisgroups.org/listinfo.cgi/sepsisgroups-sepsisgroups.org
_______________________________________________
Sepsisgroups mailing list
[email protected]
http://lists.sepsisgroups.org/listinfo.cgi/sepsisgroups-sepsisgroups.org
_______________________________________________ Sepsisgroups mailing list [email protected] http://lists.sepsisgroups.org/listinfo.cgi/sepsisgroups-sepsisgroups.org
